Google Research, in collaboration with Move37 Labs, has introduced NucleoBench, a new open-source benchmark for evaluating nucleic acid sequence design algorithms. This benchmark, which involved over 400,000 experiments across 16 biological challenges, aims to standardize the evaluation process for AI models used in drug discovery. The research also unveiled AdaBeam, a novel hybrid design algorithm that demonstrated superior performance on 11 out of 16 tasks compared to existing methods, particularly in scaling with long sequences and large predictive models. AI
IMPACT Accelerates AI-driven drug discovery by standardizing evaluation and improving algorithm performance for designing therapeutic DNA and RNA sequences.
RANK_REASON The cluster describes a new benchmark and algorithm for nucleic acid design, presented in a research paper by Google Research. [lever_c_demoted from research: ic=1 ai=1.0]
Read on Google AI / Research →
- AdaBeam
- Cory Y. McLean
- CRISPR
- deoxyribonucleic acid
- Google Research
- Move37 Labs
- NucleoBench
- ribonucleic acid
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
